These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11325754)

  • 1. Drug company lobbyist joins Oxfam's cheap drugs campaign.
    Dobson R
    BMJ; 2001 Apr; 322(7293):1011. PubMed ID: 11325754
    [No Abstract]   [Full Text] [Related]  

  • 2. Petition urges GSK and Pfizer to lower price of pneumonia vaccine.
    Kmietowicz Z
    BMJ; 2016 Apr; 353():i2455. PubMed ID: 27129726
    [No Abstract]   [Full Text] [Related]  

  • 3. Sense About Science charity joins fight against bid to prevent transparency of trials.
    Wise J
    BMJ; 2015 Jun; 350():h3428. PubMed ID: 26109395
    [No Abstract]   [Full Text] [Related]  

  • 4. Philippines joins other developing countries in limiting prices of drugs.
    Bland B
    BMJ; 2009 Aug; 339():b3151. PubMed ID: 19651688
    [No Abstract]   [Full Text] [Related]  

  • 5. GAVI's Advance Market Commitment.
    Schwalbe N; El-Ziq I
    Lancet; 2010 Feb; 375(9715):638-9. PubMed ID: 20171398
    [No Abstract]   [Full Text] [Related]  

  • 6. Support system: through charities, drug makers help people--and themselves.
    Anand G
    Wall St J (East Ed); 2005 Dec; ():A1, A10. PubMed ID: 16502554
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxfam accuses Pfizer of "moral bankruptcy".
    Watson R
    BMJ; 2001 Jul; 323(7306):186. PubMed ID: 11473905
    [No Abstract]   [Full Text] [Related]  

  • 8. Public health and company wealth.
    Ford N
    BMJ; 2003 Jun; 326(7402):1296. PubMed ID: 12805159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why drugs cost so much.
    Noonan D
    Newsweek; 2000 Sep; 136(13):22-30. PubMed ID: 11183315
    [No Abstract]   [Full Text] [Related]  

  • 10. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 11. Charity launches not-for-profit drug industry.
    Butler D
    Nature; 2002 Apr; 416(6880):465. PubMed ID: 11932709
    [No Abstract]   [Full Text] [Related]  

  • 12. Affordable drugs for developing countries.
    Chong CY
    Hong Kong Med J; 2003 Apr; 9(2):148-9. PubMed ID: 12668831
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug companies should cut prices for developing countries, says G8 report.
    Walgate R
    Bull World Health Organ; 2003; 81(1):72-3. PubMed ID: 12640481
    [No Abstract]   [Full Text] [Related]  

  • 14. Health care reform's price fight.
    Stone PH
    Natl J (Wash); 1994 Aug; 26(33):1923-4. PubMed ID: 10139263
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS and The Sunday Times.
    Blow D
    Nature; 1994 Jan; 367(6459):109. PubMed ID: 8114901
    [No Abstract]   [Full Text] [Related]  

  • 16. Embarrassed firms slash prices for AIDs drugs.
    Boseley S
    N Z Med J; 2001 Oct; 114(1141):440. PubMed ID: 11700768
    [No Abstract]   [Full Text] [Related]  

  • 17. Excess in the pharmaceutical industry.
    Angell M
    CMAJ; 2004 Dec; 171(12):1451-3. PubMed ID: 15583183
    [No Abstract]   [Full Text] [Related]  

  • 18. GSK promises to cap price of its drugs in poorest countries.
    Jack A
    BMJ; 2009 Feb; 338():b686. PubMed ID: 19224970
    [No Abstract]   [Full Text] [Related]  

  • 19. Ties between regulators and business are attacked after politician takes top job in industry.
    Lenzer J
    BMJ; 2005 Jan; 330(7482):60. PubMed ID: 15637359
    [No Abstract]   [Full Text] [Related]  

  • 20. Experiments in social responsibility.
    Herrling P
    Nature; 2006 Jan; 439(7074):267-8. PubMed ID: 16421547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.